NCT04332653 2026-03-09NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid TumorsNeoImmuneTechPhase 1/2 Completed215 enrolled 30 charts
NCT05116189 2026-03-09KEYNOTE-B96Merck Sharp & Dohme LLCPhase 3 Active not recruiting643 enrolled 17 charts 1 FDA
NCT04221945 2026-02-20KEYNOTE-A18Merck Sharp & Dohme LLCPhase 3 Completed1,060 enrolled 30 charts 1 FDA
NCT03635567 2026-02-04KEYNOTE-826Merck Sharp & Dohme LLCPhase 3 Completed617 enrolled 29 charts 1 FDA